Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Gürlevik SL"" wg kryterium: Autor


Wyświetlanie 1-2 z 2
Tytuł:
Favipiravir use in children with COVID-19 and acute kidney injury: is it safe?
Autorzy:
Ozsurekci Y; Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey. .
Oygar PD; Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gürlevik SL; Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kesici S; Division of Pediatric Intensive Care Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Ozen S; Division of Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Kurt Sukur ED; Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Gülhan B; Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Topaloglu R; Division of Pediatric Nephrology, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Bayrakci B; Division of Pediatric Intensive Care Unit, Department of Pediatrics, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Cengiz AB; Department of Pediatric Infectious Diseases, Faculty of Medicine, Hacettepe University, Ankara, Turkey.
Pokaż więcej
Źródło:
Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2021 Nov; Vol. 36 (11), pp. 3771-3776. Date of Electronic Publication: 2021 May 22.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Renal Elimination*
COVID-19 Drug Treatment*
Acute Kidney Injury/*physiopathology
Amides/*administration & dosage
COVID-19/*complications
Pyrazines/*administration & dosage
Systemic Inflammatory Response Syndrome/*drug therapy
Acute Kidney Injury/drug therapy ; Acute Kidney Injury/immunology ; Acute Kidney Injury/virology ; Adenosine Monophosphate/administration & dosage ; Adenosine Monophosphate/analogs & derivatives ; Adenosine Monophosphate/pharmacokinetics ; Adolescent ; Alanine/administration & dosage ; Alanine/analogs & derivatives ; Alanine/pharmacokinetics ; Amides/pharmacokinetics ; COVID-19/immunology ; COVID-19/virology ; Child ; Creatinine/blood ; Dose-Response Relationship, Drug ; Drug Therapy, Combination ; Female ; Glomerular Filtration Rate ; Humans ; Male ; Pyrazines/pharmacokinetics ; SARS-CoV-2/isolation & purification ; Systemic Inflammatory Response Syndrome/complications ; Systemic Inflammatory Response Syndrome/immunology ; Systemic Inflammatory Response Syndrome/virology ; Treatment Outcome
SCR Disease Name:
pediatric multisystem inflammatory disease, COVID-19 related
Czasopismo naukowe
    Wyświetlanie 1-2 z 2

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies